The value of four stage vestibular hydrops grading and asymmetric perilymphatic enhancement in the diagnosis of Menière's disease on MRI.


Journal

Neuroradiology
ISSN: 1432-1920
Titre abrégé: Neuroradiology
Pays: Germany
ID NLM: 1302751

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 19 11 2018
accepted: 03 01 2019
pubmed: 6 2 2019
medline: 4 4 2019
entrez: 6 2 2019
Statut: ppublish

Résumé

There is still a clinical-radiologic discrepancy in patients with Menière's disease (MD). Therefore, the purpose of this study was to investigate the reliability of current MRI endolymphatic hydrops (EH) criteria according to Baráth in a larger study population and the clinical utility of new imaging signs such as a supplementary fourth low-grade vestibular EH and the degree of perilymphatic enhancement (PE) in patients with Menière's disease (MD). This retrospective study included 148 patients with probable or definite MD according to the 2015 American Academy of Otolaryngology, Head and Neck Surgery criteria who underwent a 4-h delayed intravenous Gd-enhanced 3D-FLAIR MRI between January 2015 and December 2016. Vestibular EH, vestibular PE, cochlear EH, and cochlear PE were reviewed twice by three experienced readers. Cohen's Kappa and multivariate logistic regression were used for analysis. The intra- and inter-reader reliability for the grading of vestibular-cochlear EH and PE was excellent (0.7 < kappa < 0.9). The two most distinctive characteristics to identify MD are cochlear PE and vestibular EH which combined gave a sensitivity and specificity of 79.5 and 93.6%. By addition of a lower grade vestibular EH, the sensitivity improved to 84.6% without losing specificity (92.3%). Cochlear EH nor vestibular PE showed added-value. MRI using vestibular-cochlear EH and PE grading system is a reliable technique. A four-stage vestibular EH grading system in combination with cochlear PE assessment gives the best diagnostic accuracy to detect MD.

Identifiants

pubmed: 30719545
doi: 10.1007/s00234-019-02155-7
pii: 10.1007/s00234-019-02155-7
pmc: PMC6431299
doi:

Substances chimiques

Contrast Media 0
Organometallic Compounds 0
gadobutrol 1BJ477IO2L

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

421-429

Références

AJNR Am J Neuroradiol. 2008 Sep;29(8):1436-40
pubmed: 18388217
Proc R Soc Med. 1938 Sep;31(11):1317-36
pubmed: 19991672
Acta Otolaryngol. 2011 May;131(5):474-9
pubmed: 21198346
AJNR Am J Neuroradiol. 2012 Apr;33(4):773-8
pubmed: 22173762
Otol Neurotol. 2012 Oct;33(8):1375-9
pubmed: 22918115
BMJ Open. 2013 Feb 14;3(2):null
pubmed: 23418296
Jpn J Radiol. 2014 Apr;32(4):191-204
pubmed: 24500139
AJNR Am J Neuroradiol. 2014 Jul;35(7):1387-92
pubmed: 24524921
J Vestib Res. 2015;25(1):1-7
pubmed: 25882471
Magn Reson Med Sci. 2016 Jul 11;15(3):308-15
pubmed: 26841857
Nat Rev Dis Primers. 2016 May 12;2:16028
pubmed: 27170253
AJNR Am J Neuroradiol. 2016 Oct;37(10):1903-1908
pubmed: 27256854
Eur Radiol. 2017 Aug;27(8):3138-3146
pubmed: 27999985
Sci Rep. 2017 Mar 21;7(1):253
pubmed: 28325925
Eur Arch Otorhinolaryngol. 2017 Dec;274(12):4113-4120
pubmed: 28951962
Eur Radiol Exp. 2017;1(1):14
pubmed: 29708183
Otol Neurotol. 2018 Dec;39(10):1229-1234
pubmed: 30303944
Otolaryngol Head Neck Surg. 1995 Sep;113(3):181-5
pubmed: 7675476

Auteurs

Anja Bernaerts (A)

Department of Radiology, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Wilrijk, Belgium. Anja.Bernaerts@gza.be.

Robby Vanspauwen (R)

European institute for ORL-HNS, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Wilrijk, Belgium.

Cathérine Blaivie (C)

European institute for ORL-HNS, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Wilrijk, Belgium.

Joost van Dinther (J)

European institute for ORL-HNS, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Wilrijk, Belgium.

Andrzej Zarowski (A)

European institute for ORL-HNS, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Wilrijk, Belgium.

Floris L Wuyts (FL)

Antwerp University research center for Equilibrium and Aerospace, Wilrijkstraat 10, Building N012, 2610, Wilrijk, Belgium.

Stephanie Vanden Bossche (S)

Department of Radiology, AZ Jan Palfijn Ghent AV, Watersportlaan 5, 9000, Ghent, Belgium.

Erwin Offeciers (E)

European institute for ORL-HNS, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Wilrijk, Belgium.

Jan W Casselman (JW)

Department of Radiology, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Wilrijk, Belgium.
Department of Radiology, AZ Sint-Jan Hospital AV, Ruddershove 10, 8000, Bruges, Belgium.

Bert De Foer (B)

Department of Radiology, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Wilrijk, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH